DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Given Average Rating of “Moderate Buy” by Brokerages

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAYGet Free Report) have been given an average recommendation of “Moderate Buy” by the eleven ratings firms that are currently covering the company, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $35.22.

XRAY has been the subject of a number of research reports. StockNews.com lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Friday, May 3rd. Leerink Partnrs reiterated an “outperform” rating on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. The Goldman Sachs Group decreased their target price on shares of DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating for the company in a research report on Monday, May 6th. Robert W. Baird cut their price target on DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating on the stock in a research report on Friday, May 3rd. Finally, Needham & Company LLC decreased their price objective on DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating for the company in a report on Friday, May 3rd.

View Our Latest Report on DENTSPLY SIRONA

Insider Buying and Selling

In other news, Director Gregory T. Lucier purchased 3,577 shares of the stock in a transaction dated Friday, May 31st. The shares were purchased at an average price of $27.95 per share, with a total value of $99,977.15. Following the transaction, the director now owns 58,374 shares in the company, valued at approximately $1,631,553.30. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.52% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several institutional investors and hedge funds have recently bought and sold shares of the company. VisionPoint Advisory Group LLC lifted its holdings in DENTSPLY SIRONA by 104.2% in the third quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock valued at $26,000 after acquiring an additional 395 shares during the last quarter. Principal Securities Inc. acquired a new position in DENTSPLY SIRONA in the fourth quarter valued at about $26,000. Headlands Technologies LLC purchased a new position in DENTSPLY SIRONA during the fourth quarter worth about $30,000. Parkside Financial Bank & Trust increased its position in shares of DENTSPLY SIRONA by 33.3% during the fourth quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock valued at $42,000 after acquiring an additional 292 shares during the last quarter. Finally, Anchor Investment Management LLC purchased a new stake in shares of DENTSPLY SIRONA in the 4th quarter valued at approximately $47,000. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Stock Performance

Shares of DENTSPLY SIRONA stock opened at $25.45 on Monday. The company has a 50 day moving average price of $28.26 and a 200 day moving average price of $31.96. The firm has a market capitalization of $5.28 billion, a P/E ratio of -57.84, a PEG ratio of 1.13 and a beta of 1.04. The company has a quick ratio of 0.97, a current ratio of 1.43 and a debt-to-equity ratio of 0.54. DENTSPLY SIRONA has a 52 week low of $25.25 and a 52 week high of $41.65.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last posted its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, hitting the consensus estimate of $0.42. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The business had revenue of $953.00 million during the quarter, compared to the consensus estimate of $969.45 million. During the same period in the previous year, the firm posted $0.39 earnings per share. The business’s revenue for the quarter was down 2.6% compared to the same quarter last year. Sell-side analysts expect that DENTSPLY SIRONA will post 2.03 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 12th. Stockholders of record on Friday, June 28th will be paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.51%. The ex-dividend date is Friday, June 28th. DENTSPLY SIRONA’s dividend payout ratio is presently -145.45%.

DENTSPLY SIRONA Company Profile

(Get Free Report

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Stories

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.